NEW YORK & NEW JERSEY LAW OFFICES
Daniel R. Lapinski - Attorney at Law
Practice Areas:
Class Action Litigation,
Mass Tort Litigation
Areas of Emphasis:
Product Liability,
Consumer Protection,
Securities Fraud,
Consumer Fraud
Bar Admission:
New Jersey
New York, First Department
Pennsylvania
United States Court of Appeals (First Circuit; Third Circuit; Fourth Circuit;
and Tenth Circuit)
United States District Courts (District of New Jersey; Eastern District of New York, Southern District of New York; Eastern District of Pennsylvania; and Middle District of Pennsylvania)
Supreme Court of the United States
Education:
J.D., Seton Hall University School of Law, 1999
B.A., Rutgers University, 1990
Biographical Information:
Daniel R. Lapinski is a shareholder with Wilentz, Goldman & Spitzer, P.A. in Woodbridge, New Jersey, and is a member of the firm’s Mass Tort Class Action Group. He concentrates his practice on complex litigation, including class actions alleging violations of consumer protection laws, unfair trade practices, wage & hour claims and securities fraud, and mass tort litigation representing victims who have been harmed by dangerous pharmaceutical products and medical devices.
Mr. Lapinski has had significant involvement in complex cases. He has successfully argued federal preemption issues before the United States Court of Appeals for the Third Circuit and has been actively involved in the resolution of noteworthy cases, including: In re Ford Explorer Cases, JCCP Nos. 4266 & 4270, a California class action that was settled on behalf of nearly one million vehicle owners residing in California, Connecticut, Illinois and Texas following 50 days of trial in Sacramento, California; Alexander v. Solvay Pharmaceuticals, Inc., Case No. BC300364, a $30 million settlement on behalf of a class of California purchasers of a pharmaceutical product that was alleged to have been falsely and deceptively advertised; Slaughter v. Unilever United States, Inc., Civil Action No. 09-cv-2027 (D.N.J.), a nationwide settlement on behalf of a class of consumers who purchased Super Shots, a fruit blend product deceptively alleged to help control blood pressure; In re: Ortho Evra Birth Control Patch Litigation, a mass tort litigation involving injuries and damages resulting from the use of a transdermal birth control patch; In re: Propulsid Litigation, a mass tort litigation involving injuries and damages resulting from the use of a drug prescribed for the treatment of acid reflux; and In re: Rezulin Litigation, a mass tort litigation involving injuries and damages resulting form the use of a drug prescribed for the treatment of diabetes. Mr. Lapinski has also successfully argued federal preemption issues before the United States Court of Appeals for the Third Circuit.
At present, Mr. Lapinski serves as a member of the Plaintiffs’ Steering Committee in In re: Heparin Products Liab. Litig., MDL Docket No. 1953, and is class counsel in several pending, complex commercial matters. He has also served as a panelist and spoken on topics related to class action and mass tort litigation.
Mr. Lapinski is a member of the American Association for Justice (AAJ), the National Association of Shareholder and Consumer Attorneys (NASCAT), the New Jersey Association for Justice (NJAJ), the New Jersey State Bar Association and the New York State Bar Association, and has recently been recognized by New Jersey Super Lawyers® - Rising Stars for 2011, an honor bestowed upon attorneys practicing for ten years or less who have obtained a high degree of peer reorganization and achievement.
Direct Telephone: (732) 855-6066
Direct Fax: (732) 726-4735
» top
